Search Medical Condition
Please enter condition
Please choose location

Lierskogen, Norway Clinical Trials

A listing of Lierskogen, Norway clinical trials actively recruiting patients volunteers.

RESULTS

Found (49) clinical trials

A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

In the majority of European countries, the primary management of chronic heart failure patients is performed by General Practitioners in collaboration with cardiologists (specialists). Previous studies have shown that many patients suffering from CHF do not receive optimal pharmacological and/or device treatment for their disease. An increase in natriuretic peptides ...

Phase

0.0 miles

Learn More »

Comprehensive Follow-up of Low Income Families. A Cluster-randomized Study

Comprehensive follow up of low-income families. A cluster-randomised study. Start 1.1 2016, Finnish 31.5 2019 Funding: Norwegian Labour and Welfare Administration Collaboration Norwegian Labour and Welfare Administration Labour and Welfare offices: NAV Alna, NAV Asker, NAV Bergenhus, NAV Bjerke, NAV Bod, NAV Brum, NAV Elverum, NAV Fana, NAV Frogner, NAV ...

Phase N/A

3.13 miles

Learn More »

Better Hips- Better Function

The focus of this project are elderly people who have experienced hip fracture and need at least two weeks rehabilitation after discharge from hospital. The aim is to increase the evidence-based knowledge base for planning and appropriate follow-up intervention for patients with hip fracture on short-term / rehabilitation stays. In ...

Phase N/A

6.01 miles

Learn More »

AZD9291 an Irreversible EGFR-TKI in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI Coupled to Extensive Translational Studies

This is a phase II, single-arm study to assess the safety and efficacy of AZD9291 (80 mg, orally, once daily) in second-line (or later) patients with EGFR mutation-positive, locally advanced or metastatic NSCLC, who have progressed following treatment with an approved epidermal growth factor tyrosine kinase inhibitor agent. If feasible, ...

Phase

6.72 miles

Learn More »

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

This registry is a prospective, multi-center, observational study and will collect safety data on multiple myeloma adult patients who have received at least two prior therapies and take IMNOVID (pomalidomide) as part of standard care. The registry will remain open until 500 patients will have received at least 3 cycles ...

Phase N/A

6.72 miles

Learn More »

Treatment Results After Acute Rupture of the Achilles Tendon.

Patients are randomized to either surgery or non-operative treatment. Surgery will be performed by open technique or by using a mini-invasive approach. Open surgery remains widespread and arguably the best documented treatment, however mini-invasive surgery is also included because of its potential to lessen the risk of wound complications. Michael ...

Phase N/A

6.72 miles

Learn More »

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

Device-detected sub-clinical atrial fibrillation (SCAF) is a new disorder that has been recognized since the availability of implantable devices capable of long term continuous heart rhythm monitoring. It is characterized by one or more runs of rapid atrial arrhythmia detected by the device without symptoms and without any clinical atrial ...

Phase

6.72 miles

Learn More »

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

6.72 miles

Learn More »

Biology of Juvenile Myoclonic Epilepsy

Epilepsy is a common neurological disorder affecting 1% of the population. There are over 30 types of epilepsy, some common, some rare. Most epilepsies arise in childhood and have a genetic cause. Approximately 40% of patients have the common forms of Genetic Generalised Epilepsy (GGE), and the commonest GGE is ...

Phase N/A

6.72 miles

Learn More »

NSAIDs in Sciatica NSAIDS IN SCIATICA

Sciatica is an established term for pain radiating from the lower back or buttock into the leg, commonly caused by a disc herniation. Given their analgesic and anti-inflammatory mechanisms of action, NSAIDs (Non-steroidal anti-inflammatory drugs) have been, and are still being regarded as standard therapy for sciatica. However, very few ...

Phase

6.72 miles

Learn More »